Latest current affairs · 20 Nov
Enrol · ₹3,500
Latest current affairs20 Nov
Skip to content

Novel Gene Therapy: one-time solution for Haemophilia

1 min read
All exams GA
In one line

Context:

Novel Gene Therapy: one-time solution for Haemophilia
Credit: The Hindu

Scientists in India have reported success with using gene therapy to treat severe haemophilia A, a rare hereditary condition resulting from a faulty gene which triggers severe, spontaneous, and potentially fatal bleeding episodes.

Key Highlights:

  • Hemophilia A is a rare, inherited bleeding disorder that occurs when the body doesn’t produce enough factor VIII, a protein that helps blood clot.
  • No bleeding incidences were detected after an average 14 months of follow-up evaluation post-gene therapy in a trial led by Alok Srivastava of the Centre for Stem Cell Research (CSCR), Christian Medical College at Vellore.
  • A one-time therapy is gene therapy and aims to introduce a gene into the body where that would produce enough amount of the clotting factor so that it will not bleed.
  • Despite being rare in India, it is home to the second-largest population of patients who had someday 0.4-1 lakh estimates.
Free PDF · print or read offline Download this page as a PDF

A clean PDF of this page with the C4S header — it opens right away, and the link comes to your WhatsApp too.

The link opens at once. After that, only study material and course updates. No spam.

Related on Clarity 4 Sure

WhatsApp